1 | 1 | | By: Taylor of Collin, et al. S.B. No. 1583 |
---|
2 | 2 | | (Fletcher) |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to classifying synthetic cannabinoid or cathinone as a |
---|
8 | 8 | | Schedule I controlled substance under the Texas Controlled |
---|
9 | 9 | | Substances Act; affecting the prosecution of a criminal offense. |
---|
10 | 10 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
11 | 11 | | SECTION 1. Subchapter B, Chapter 481, Health and Safety |
---|
12 | 12 | | Code, is amended by adding Section 481.038 to read as follows: |
---|
13 | 13 | | Sec. 481.038. SYNTHETIC CANNABINOID OR CATHINONE. |
---|
14 | 14 | | (a) Schedule I includes any synthetic cannabinoid or cathinone |
---|
15 | 15 | | designer drug that is not regulated by the United States Food and |
---|
16 | 16 | | Drug Administration or by the laws of this state but that is similar |
---|
17 | 17 | | by structure or pharmacological effect to a Schedule I or II |
---|
18 | 18 | | controlled substance that is regulated under federal law or the |
---|
19 | 19 | | laws of this state. For purposes of this section, a substance is |
---|
20 | 20 | | similar by structure or pharmacological effect to a Schedule I or II |
---|
21 | 21 | | controlled substance if the substance contains a majority of |
---|
22 | 22 | | functional features in a similar chemical structural arrangement or |
---|
23 | 23 | | otherwise mimics the pharmacological effect of a Schedule I or II |
---|
24 | 24 | | controlled substance. |
---|
25 | 25 | | (b) Any compound of a designer drug described by Subsection |
---|
26 | 26 | | (a) that is manufactured, formulated, sold, distributed, or |
---|
27 | 27 | | marketed with the intent to circumvent the law under this chapter or |
---|
28 | 28 | | federal law is a Schedule I controlled substance. |
---|
29 | 29 | | (c) Examples of synthetic cannabinoid designer drugs |
---|
30 | 30 | | include substances that are generated using a three-component |
---|
31 | 31 | | pharmacophore model. Synthetic cannabinoid designer drugs that |
---|
32 | 32 | | contain one or more components of a controlled substance in |
---|
33 | 33 | | Schedule I or II under federal or state law are analogues of |
---|
34 | 34 | | Schedule I or II controlled substances. |
---|
35 | 35 | | (d) Nothing in this section affects an exemption provided |
---|
36 | 36 | | under state law to a person who possesses for a lawful purpose a |
---|
37 | 37 | | chemical formula defined as a controlled substance. |
---|
38 | 38 | | SECTION 2. This Act takes effect September 1, 2015. |
---|